Molecular Pharmacology: 42 (2)

August 01, 1992; Volume 42,Issue 2

You have access
Novel amiloride analog allosterically modulates the alpha 2-adrenergic receptor but does not inhibit Na+/H+ exchange.
A L Wilson, S W Womble, C Prakash, E J Cragoe, I A Blair and L E Limbird

Molecular Pharmacology August 1992, 42 (2) 175-179;
You have access
Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.
J M Zgombick, L E Schechter, M Macchi, P R Hartig, T A Branchek and R L Weinshank

Molecular Pharmacology August 1992, 42 (2) 180-185;
You have access
Action of thrombin receptor polypeptide in gastric smooth muscle: identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity.
M D Hollenberg, S G Yang, A A Laniyonu, G J Moore and M Saifeddine

Molecular Pharmacology August 1992, 42 (2) 186-191;
You have access
Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn.
D Bleakman, K I Rusin, P S Chard, S R Glaum and R J Miller

Molecular Pharmacology August 1992, 42 (2) 192-196;
You have access
Immortalized hypothalamic GT1-7 neurons express functional gamma-aminobutyric acid type A receptors.
T G Hales, H Kim, B Longoni, R W Olsen and A J Tobin

Molecular Pharmacology August 1992, 42 (2) 197-202;
You have access
Biochemical characterization of kainate receptors from goldfish brain.
C J Ziegra, J M Willard and R E Oswald

Molecular Pharmacology August 1992, 42 (2) 203-209;
You have access
N-methyl-D-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cells.
D M Chuang, X M Gao and S M Paul

Molecular Pharmacology August 1992, 42 (2) 210-216;
You have access
Association of solubilized angiotensin II receptors with phospholipase C-alpha in murine neuroblastoma NIE-115 cells.
S J Mah, A M Ades, R Mir, I R Siemens, J R Williamson and S J Fluharty

Molecular Pharmacology August 1992, 42 (2) 217-226;
You have access
Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue.
R Seifert, A Höer, S Offermanns, A Buschauer and W Schunack

Molecular Pharmacology August 1992, 42 (2) 227-234;
You have access
Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation.
R Seifert, A Höer, I Schwaner and A Buschauer

Molecular Pharmacology August 1992, 42 (2) 235-241;
You have access
A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro-2'-deoxyuridine in mammalian and bacterial cells.
K W Barbour, D K Hoganson, S H Berger and F G Berger

Molecular Pharmacology August 1992, 42 (2) 242-248;
You have access
Null phenotype for cytochrome P450 2B2 in the rat results from a deletion of its structural gene.
C J Omiecinski, R Ramsden, A Rampersaud and F G Walz

Molecular Pharmacology August 1992, 42 (2) 249-256;
You have access
Sequence analysis, in vitro translation, and expression of the cDNA for rat liver minoxidil sulfotransferase.
S J Hirshey, T P Dooley, I M Reardon, R L Heinrikson and C N Falany

Molecular Pharmacology August 1992, 42 (2) 257-264;
You have access
Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products.
K J Martell, G N Levy and W W Weber

Molecular Pharmacology August 1992, 42 (2) 265-272;
You have access
Transcriptional regulation of rat microsomal epoxide hydrolase gene by imidazole antimycotic agents.
S G Kim

Molecular Pharmacology August 1992, 42 (2) 273-279;
You have access
Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
M Bourdi, J C Gautier, J Mircheva, D Larrey, A Guillouzo, C Andre, C Belloc and P H Beaune

Molecular Pharmacology August 1992, 42 (2) 280-285;
You have access
Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
R B Perich, B Jackson, F Rogerson, F A Mendelsohn, D Paxton and C I Johnston

Molecular Pharmacology August 1992, 42 (2) 286-293;
You have access
Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.
J D Petke, H K Im, W B Im, D P Blakeman, J F Pregenzer, E J Jacobsen, B J Hamilton and D B Carter

Molecular Pharmacology August 1992, 42 (2) 294-301;
You have access
Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs.
L Ghoda, H S Basu, C W Porter, L J Marton and P Coffino

Molecular Pharmacology August 1992, 42 (2) 302-306;
You have access
Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins. II.
S M Kimmett, R A Whitney and G S Marks

Molecular Pharmacology August 1992, 42 (2) 307-310;
You have access
Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
J Hu, S Z Wang, C Forray and E E el-Fakahany

Molecular Pharmacology August 1992, 42 (2) 311-321;
You have access
Both enantiomers of 1-aminocyclopentyl-1,3-dicarboxylate are full agonists of metabotropic glutamate receptors coupled to phospholipase C.
O Manzoni, L Prezeau, F A Rassendren, F Sladeczek, K Curry and J Bockaert

Molecular Pharmacology August 1992, 42 (2) 322-327;
You have access
Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
S Leonhardt, E Gorospe, B J Hoffman and M Teitler

Molecular Pharmacology August 1992, 42 (2) 328-335;
You have access
Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands.
P Nambi, H L Wu, M Pullen, N Aiyar, H Bryan and J Elliott

Molecular Pharmacology August 1992, 42 (2) 336-339;
You have access
Cyclic AMP potentiates receptor-stimulated phosphoinositide hydrolysis in human neuroepithelioma cells.
S K Fisher, E L McEwen, S C Lovell and R E Landon

Molecular Pharmacology August 1992, 42 (2) 340-346;
You have access
Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
P Robberecht, P Gourlet, P De Neef, M C Woussen-Colle, M C Vandermeers-Piret, A Vandermeers and J Christophe

Molecular Pharmacology August 1992, 42 (2) 347-355;
You have access
Effects of oxidizing and reducing analogs of acetylcholine on neuronal nicotinic receptors.
Y Xie, G S Jones and R H Loring

Molecular Pharmacology August 1992, 42 (2) 356-363;
You have access
Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines.
J J Enyeart, B A Biagi and B Mlinar

Molecular Pharmacology August 1992, 42 (2) 364-372;
You have access
Theoretical studies on the histamine H2 receptor: molecular mechanism of action of antagonists.
J Giraldo, M Martín, M Campillo and L Pardo

Molecular Pharmacology August 1992, 42 (2) 373-381;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals